KIR2DL3 and rheumatoid arthritis: The proportion of CD8+ EMRA cells that express KIR2DL3 which is a marker of regulatory CD8+ T cells38 and CD69 was significantly increased in both ACPA+ and ACPA− RA as compared to HCs (Supplementary Fig. 2b, c).